BDIP 0001

Drug Profile

BDIP 0001

Alternative Names: BDIP-0001

Latest Information Update: 17 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator CareFusion
  • Class Antiseptics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Bacterial infections

Most Recent Events

  • 17 Mar 2017 CareFusion completes a phase II trial in Bacerial infections (Prevention) in USA (Topical) (NCT03140254)
  • 01 Sep 2016 Phase-II clinical trials in Bacterial infections (Prevention) in USA (Topical) (NCT03140254)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top